Daily News Archive
Daily News Subscription
Viz Vitae Highlights Stem Cell Therapy
How does a horse with a previously bowed tendon win a race by 20-lengths? The weekend victory of stem cell therapy recipient Viz Vitae by that margin in the Moonee Valley Hurdle (3210m) followed his Benalla Cup win in the spring & also a hurdle win at Sandown on June 25. Viz Vitae part-owner & Lindsay Park veterinarian Dr Campbell Baker enthused: "This horse suggests to us at Lindsay Park that no matter how severe the tendon injury, stem cells promise a complete regeneration of the damaged tissue. While it is too soon to comment on the long-term outcomes of Vet Biotechnology's therapy, early results in terms of returning injured horses to the racetrack have been nothing short of stunning." Viz Vitae's trainer David Hayes also produced stem cell recipient Gorky Park to win the Andrew Ramsden Stakes (3200m) in the autumn & that stayer is now back in work at Lindsay Park in preparation for November's Gr1 Melbourne Cup. To cap a great weekend for Vet Biotechnology, Lanson (which has had autologous stem cell tendon implants in both forelegs) won The Metric Mile in Darwin. Vet Biotechnology general manager David Bridgland declared stem cell therapy "is fast becoming the orthopaedic treatment of the 21st century" & noted: "Friday is August 1, the birthday for all thoroughbreds in the Southern Hemisphere, and ushers in the foaling season & the opportunity to collect stem cells from the umbilical cord at birth. The stem cells derived from the umbilical cord are cryo-stored for the life of the horse in readiness for the treatment of injury & illness. Collecting the cord is like an insurance policy & will be a reassuring bonus for breeders who race their own produce & yearling buyers alike."